Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 78: 1853-1858, 1995;
8750-7587/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, S. J.
Right arrow Articles by Spriet, L. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, S. J.
Right arrow Articles by Spriet, L. L.

Journal of Applied Physiology, Vol 78, Issue 5 1853-1858, Copyright © 1995 by American Physiological Society


ARTICLES

Skeletal muscle phosphofructokinase activity examined under physiological conditions in vitro

S. J. Peters and L. L. Spriet
School of Human Biology, University of Guelph, Ontario, Canada.

The in vitro activity of skeletal muscle phosphofructokinase (PFK) was determined over the full physiological range of citrate concentrations. Enzyme aggregation was enhanced with a crowding agent, as the regulatory properties of PFK are altered with dilution. Cuvette conditions simulated concentrations of effectors and substrates during rest, moderate aerobic exercise, and intense aerobic exercise in human skeletal muscle. Citrate inhibition was not eliminated with enhanced enzyme aggregation, but activity was improved at all citrate concentrations. Maximal PFK activity with no citrate present was 0.27 +/- 0.01 mumol.min-1.mg-1 protein with resting effectors and 1.64 +/- 0.07 and 7.15 +/- 0.52 mumol.min-1.mg-1 protein with moderate aerobic and intense aerobic effector levels, respectively. Under resting conditions, PFK activity decreased to 49% of maximal when citrate was increased from 0 to 0.15 mM and only a small further inhibition to 43% occurred at 0.5 mM. Citrate was a less potent inhibitor under both exercise conditions with the sharpest decline to 72-77% of maximal activity at 0.15 mM followed by a slower decline to 65-70 and 53% activity at 0.25 and 0.5 mM citrate, respectively. The present in vitro measurements predict that alterations in citrate around concentrations normally reported in resting and exercising muscle would have little effect on flux through PFK. Therefore, the generally accepted concept that citrate is a potent inhibitor of PFK in all physiological situations has been exaggerated.


This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
A. E. JEUKENDRUP
Regulation of Fat Metabolism in Skeletal Muscle
Ann. N.Y. Acad. Sci., June 1, 2002; 967(1): 217 - 235.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. A. Timmons, S. M. Poucher, D. Constantin-Teodosiu, I. A. Macdonald, and P. L. Greenhaff
Regulation of skeletal muscle carbohydrate oxidation during steady-state contraction
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1384 - R1389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Odland, G. J. F. Heigenhauser, D. Wong, M. G. Hollidge-Horvat, and L. L. Spriet
Effects of increased fat availability on fat-carbohydrate interaction during prolonged exercise in men
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R894 - R902.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. G. Richards, G. J. F. Heigenhauser, and C. M. Wood
Glycogen phosphorylase and pyruvate dehydrogenase transformation in white muscle of trout during high-intensity exercise
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R828 - R836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online